TY - JOUR T1 - SARS-CoV-2 Acquisition and Immune Pathogenesis Among School-Aged Learners in Four Diverse Schools JF - medRxiv DO - 10.1101/2021.03.20.21254035 SP - 2021.03.20.21254035 AU - Dan M. Cooper AU - Michael Z. Zulu AU - Allen Jankeel AU - Izabela Coimbra Ibraim AU - Jessica Ardo AU - Kirsten Kasper AU - Diana Stephens AU - Andria Meyer AU - Annamarie Stehli AU - Curt Condon AU - Mary E. Londoño AU - Casey M. Schreiber AU - Nanette V. Lopez AU - Ricky L. Camplain AU - Michael Weiss AU - Charles Golden AU - Shlomit Aizik AU - Bernadette Boden-Albala AU - Clayton Chau AU - Ilhem Messaoudi AU - Erlinda R. Ulloa Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/06/16/2021.03.20.21254035.abstract N2 - Background Understanding SARS-CoV-2 infection in children is necessary to reopen schools safely.Methods We measured SARS-CoV-2 infection in 320 learners [10.5 ± 2.1(sd); 7-17 y.o.] at four diverse schools with either remote or on-site learning. Schools A and B served low-income Hispanic learners; school C served many special-needs learners; and all provided predominantly remote instruction. School D served middle- and upper-income learners, with predominantly on-site instruction. Testing occurred in the fall (2020), and 6-8 weeks later during the fall-winter surge (notable for a tenfold increase in COVID-19 cases). Immune responses and mitigation fidelity were also measured.Results We found SARS-CoV-2 infections in 17 learners only during the surge. School A (97% remote learners) had the highest infection (10/70, 14.3%, p<0.01) and IgG positivity rates (13/66, 19.7%). School D (93% on-site learners) had the lowest infection and IgG positivity rates (1/63, 1.6%). Mitigation compliance [physical distancing (mean 87.4%) and face covering (91.3%)] was remarkably high at all schools. Documented SARS-CoV-2-infected learners had neutralizing antibodies (94.7%), robust IFN-γ+ T cell responses, and reduced monocytes.Conclusion Schools can implement successful mitigation strategies across a wide range of student diversity. Despite asymptomatic to mild SARS-CoV-2 infection, children generate robust humoral and cellular immune responses.Key PointsSuccessful COVID-19 mitigation was implemented across a diverse range of schools.School-associated SARS-CoV-2 infections reflect regional rates rather than remote or on-site learning.Seropositive school-aged children with asymptomatic to mild SARS-CoV-2 infections generate robust humoral and cellular immunity.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNIH NCATS UCI Clinical and Translational Science Award UL1 TR001414; R01AI142841; R21AI143301; Orange County Health Care Agency Research Fund; UCI COVID-19 Research Fund; Support was provided in part by the Robert Wood Johnson Foundation and the National Institute of Allergy and Infectious Diseases, NIH (K08 AI151253-01) to ERU.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by the institutional review boards at the Childrens Hospital of Orange County and the University of California IrvineAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data that support the findings of this study are openly available in medRxiv.CHOCChildren’s Hospital of Orange CountyOCHCAOrange County Health Care AgencySOCOMSystematic Observation of COVID-19 MitigationHDLhigh-density lipoproteinLDLlow-density lipoproteinPBMCsperipheral blood mononuclear cellsNPnucleocapsid proteinRBDreceptor binding domainNKnatural killer cellsmDCsmyeloid dendritic cellsPD-1programmed death cell protein 1MFImean fluorescence intensity ER -